Bio Green Med Solution, Inc.

Regulatory Filings • Mar 31, 2025

NT 10-K 1 cyclacel_nt10k.htm NT 10-K

Field: Rule-Page

Field: /Rule-Page

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING
OMB Number:	3235-0058
Expires:	April 30, 2025
Estimated average burden hours per response ....……..2.50
SEC FILE NUMBER
000-50626
CUSIP NUMBER 23254L801

(Check one):	☐ Form 20-F	☐ Form 11-K
☐ Form 10-Q	☐ Form 10-D	☐ Form N-CEN	☐ Form N-CSR
For Period Ended: December 31, 2024
☐ Transition Report on Form 10-K
☐ Transition Report on Form 20-F
☐ Transition Report on Form 11-K
☐ Transition Report on Form 10-Q
For the Transition Period Ended: ______

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I — REGISTRANT INFORMATION

CYCLACEL PHARMACEUTICALS, INC.

Field: Rule-Page

Field: /Rule-Page

Full Name of Registrant

Field: Rule-Page

Field: /Rule-Page

Former Name if Applicable

Level 10, Tower 11, Avenue 5, The Horizon

Bangsar South City, No. 8, Jalan Kerinchi

Field: Rule-Page

Field: /Rule-Page

Address of Principal Executive Office (Street and Number)

59200, Kuala Lumpur, Malaysia

Field: Rule-Page

Field: /Rule-Page

City, State and Zip Code

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

	(a)	The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
☒	(b)	The subject annual report on Form 10-K or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; and
	(c)	The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III — NARRATIVE

State below in reasonable detail the reasons why Form 10-K could not be filed within the prescribed time period.

Cyclacel Pharmaceuticals, Inc. (the “Company”) has determined that it is unable to file, without unreasonable effort or expense, its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Form 10-K”) by the prescribed due date, as it requires additional time to gather necessary information for the preparation of such Form 10-K. The Company does, however, expect to file such report within fifteen calendar days thereof.

PART IV — OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

Datuk Dr. Doris Wong Sing Ee	(908)	517-7330
(Name)	(Area Code)	(Telephone Number)

(2)	Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
	Yes ☒ No ☐
(3)	Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
	Yes ☐ No ☒
	If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

Field: Page; Sequence: 2; Options: NewSection; Value: 2

Field: Sequence; Type: Arabic; Name: PageNo 2 Field: /Sequence of 3

Field: /Page

Cyclacel Pharmaceuticals, Inc.

Field: Rule-Page

Field: /Rule-Page

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date :	/s/ Datuk Dr. Doris Wong Sing Ee
Title:	Chief Executive Officer

Field: Page; Sequence: 3; Value: 2

Field: Sequence; Type: Arabic; Name: PageNo 3 Field: /Sequence of 3

Field: /Page